Organogenesis Holdings Inc (ORGO)
2.86
+0.07
(+2.51%)
USD |
NASDAQ |
Apr 18, 16:00
2.87
+0.01
(+0.35%)
Pre-Market: 20:00
Organogenesis Holdings Gross Profit Margin (Quarterly): 72.13% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 72.13% |
| September 30, 2023 | 76.24% |
| June 30, 2023 | 77.57% |
| March 31, 2023 | 75.28% |
| December 31, 2022 | 76.53% |
| September 30, 2022 | 77.60% |
| June 30, 2022 | 78.05% |
| March 31, 2022 | 74.18% |
| December 31, 2021 | 74.51% |
| September 30, 2021 | 77.00% |
| June 30, 2021 | 75.70% |
| March 31, 2021 | 75.14% |
| December 31, 2020 | 76.11% |
| September 30, 2020 | 77.22% |
| June 30, 2020 | 70.94% |
| Date | Value |
|---|---|
| March 31, 2020 | 69.56% |
| December 31, 2019 | 72.68% |
| September 30, 2019 | 70.23% |
| June 30, 2019 | 70.06% |
| March 31, 2019 | 70.27% |
| December 31, 2018 | 72.47% |
| September 30, 2018 | 61.64% |
| June 30, 2018 | 60.28% |
| March 31, 2018 | 59.13% |
| December 31, 2017 | 70.82% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 65.28% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
69.56%
Minimum
Mar 2020
78.05%
Maximum
Jun 2022
74.56%
Average
75.28%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 1.82% |
| Return on Assets | 1.09% |
| Return on Invested Capital | 1.46% |
| Profit Margin (Quarterly) | -0.57% |
| Operating Margin (Quarterly) | -1.27% |
| Return on Net Operating Assets | 1.53% |